Furthermore, BMI1 was shown to be overexpressed in CML vs control subjects [91] with an increased expression that mirrors disease progression [91,92] and could thus represent a molecular marker for CML prognosis prediction [93] Moreover, BMI1 could be a potential target. Here, BMI1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.